Search

Search Constraints

You searched for: Author/Creator Wirth, Lori J.

Search Results

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016. (8th December 2016)

2. 57 Local Control Following Combination Hypofractionated Radiotherapy and Pembrolizumab in a Phase II Trial of Recurrent or Metastatic Adenoid Cystic Carcinoma Patients. (October 2019)

3. A phase 2 study of dalantercept, an activin receptor‐like kinase‐1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Issue 23 (20th September 2016)

4. A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma. (August 2021)

5. American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment. Issue 6 (11th March 2022)

6. Biomarkers predictive of response to pembrolizumab in head and neck cancer. (7th December 2022)

7. Cell‐free human papillomavirus DNA kinetics after surgery for human papillomavirus–associated oropharyngeal cancer. Issue 11 (9th February 2022)

8. Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma. (29th March 2019)

9. Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer. Issue 24 (15th August 2016)